Health Condition 1: null- STABLE SCHIZOPHRENIA
Conditions
Interventions
Intervention1: escitalopram: escitalopram is an antidepressant
Control Intervention1: Escitalopram and placebo: Escitalopram 10mg 1HS for 8 weeks
Placebo 1 capsules 1HS for 8 weeks
Sponsors
Pooja Singh
Eligibility
Inclusion criteria
Inclusion criteria: 1)Patients aged between 18 to 50 years. 2)Availability of a reliable informant. 3)Written informed consent from the patient and/or informant. 4)Diagnosis of Schizophrenia as per ICD-10, DCR. 5)Satisfying operational definition of stable schizophrenia. 6)Having SSDs as defined for the purpose of this study
Exclusion criteria
Exclusion criteria: 1)Patients having clinically significant medical disorder / disability or taking treatment for same. 2)Any comorbid psychiatric disorder other than nicotine dependence. 3)Patients already receiving antidepressants or mood stabilisers during last 8 weeks. 4)Patients who have received electroconvulsive therapy, other somatic treatments or any form of Psychotherapy during the last six months. 5)Any significant abnormality in routine investigations at baseline (Hb, TLC, DLC, RBS, S.Urea, S.Creatinine, LFT) 6)Pregnant and lactating females.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| PANSS, HAM-D, SOFAS, SCoRSTimepoint: at 8 weeks | — |
Secondary
| Measure | Time frame |
|---|---|
| PANSS, SOFAS, HAM-D, SCoRSTimepoint: 4 WEEKS | — |
Countries
India
Contacts
Public ContactPooja Singh
KGMU, LUCKNOW
Outcome results
None listed